Ovarian Cancer Antigen CA 125 Enhances the Invasiveness of the Endometriotic Cell Line EEC 145

Abstract

Objective: Ovarian cancer antigen CA 125 is used widely for diagnostic and therapeutic evaluation of ovarian cancer. Although the initial description of CA 125 was in 1981, its function is still unknown. In collagen gel system the invasiveness of the endometriotic cell line EEC 145 is enhanced by a proteinaceous factor in peritoneal fluid mimicking molecular features of CA 125. Therefore we hypothesize that this factor is CA 125.

Methods: The influence of heat-treated peritoneal fluid on the invasiveness of the endometriotic cell line EEC 145 and several human carcinoma cell lines (EJ28, RT112, AN3 CA, RL95-2, HEC-1-A, HeLa, MCF7, T-47D, and SK-OV-3) was investigated in a collagen gel invasion assay by addition of (1); 10% heat-treated peritoneal fluid, (2); peritoneal fluid after immunoprecipitation with antibodies directed to CA 125, and (3); purified CA 125.

Results: The invasion index of the endometriotic cell line EEC 145 significantly increased from 4.78 ± 0.98 to 6.57 ± 1.58 (P = .0001) by addition of 10% heat-treated peritoneal fluid to the culture medium. The invasion-promoting effect of peritoneal fluid was abolished by reductions of the CA 125 concentration through immunoprecipitation and was mimicked in a dose-dependent manner by addition of CA 125 to the culture medium. The invasiveness of the investigated human carcinoma cell lines was not affected by heat-treated peritoneal fluid or CA 125.

Conclusion: The results are consistent with the hypothesis that CA 125 can influence invasiveness in a benign endometriotic cell line.

Keywords

Endometriosis adhesion molecule invasion

Get full access to this article

View all access options for this article.

References

1. Bast RC , Feeney M , Lazarus H , Colvin RB , Knapp RC . Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest 1981;68:1331-1337.

2. Lloyd KO , Yin BWT , Kudryashov V . Isolation and characterization of ovarian cancer antigen CA 125 using a new monoclonal antibody (VK-8): Identification as a mucine-type molecule. Int J Cancer 1997;71:842-850.

3. Onsrud M , Shabana A , Austgulen R , Nustad K . Comparison between soluble tumor necrosis factor receptors and CA 125 in peritoneal fluid as a marker for epithelial ovarian cancer. Gynecol Oncol 1995;57:183-187.

4. Gaetje R , Kotzian S , Herrmann G , Baumann R , Starzinski-Powitz A . Invasiveness of endometriotic cells in vitro. Lancet 1995;346:1463-1464.

5. Gaetje R , Starzinski-Powitz, A , Kotzian A , Baumann R . Invasiveness of endometriotic cells in vitro. Arch Gynecol Obstet 1996;258(Suppl):146-146.

6. Ramey JW , Archer, DF . Peritoneal fluid: Its relevance to the development of endometriosis. Fertil Steril 1993;60:1-14.

7. Gaetje R , Kotzian S , Herrmann G , Baumann R , Starzinski-Powitz A . Non-malignant epithelial cells, potentially invasive in human endometriosis, lack the tumor suppressor molecule E-cadherin. Am J Pathol 1997;150:461-467.

8. Frixen UH , Behrens J , Sachs M , et al. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 1991;113:173-185.

9. Kruitwagen RF , Poels LG , Willensem WN , De Ronde IJK , Jap PHK , Rolland R . Endometrial epithelial cells in peritoneal fluid during the early follicular phase. Fertil Steril 1991;55:297-293.

10.

10. Maatsubara J , Mizunuma H , Nagumo H , Ibuki Y . Tissue distribution of CA 125 in female reproductive organs. Nippon Sanka Fujinka Gakka Zasshi 1988;40:568-574.

11.

11. O'Brien TJ , Tanimoto H , Konishi I , Gee M . More than 15 years of CA 125: What is known about the antigen, its structure and its function. Int J Biol Markers 1998;13:188-195.